Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: J Heart Lung Transplant. 2021 Aug 25;40(12):1641–1648. doi: 10.1016/j.healun.2021.08.005

Table 2.

Transplant Rates Compared Across Diagnosis Groups

Outcome Obstructive lung disease – Group A
n = 40
Pulmonary arterial hypertension – Group B
n = 97
Cystic fibrosis – Group C
n = 138
Interstitial lung disease – Group D
n = 789
Transplantation, No. (%) 29 (72.5) 48 (49.5) 102 (73.9) 492 (62.4)
Transplant rate, transplants per person years on waitlist on ECMO 15.41 6.05 15.66 15.62
Unadjusted SHR for transplant (95% CI) 1.63 (1.08–2.48) 1 1.83 (1.33–2.53) 1.51 (1.13–2.02)
Adjusteda SHR for transplant 1.78 (1.17–2.71) 1 1.69 (1.22–2.34) 1.62 (1.21–2.17)

Abbreviations: CI, confidence interval; ECMO, extracorporeal membrane oxygenatation; SHR, sub-distribution hazard ratio.

The bold values are statistically significant based on the statistical analysis used (i.e. the confidence interval does not cross 1, and the p-value was <0.05).

a

Adjusted for age at the time of waitlist activation, ABO blood type, height, and listing only for double lung transplant.